List of bibliographic references
Number of relevant bibliographic references: 19.
| Ident. | Authors (with country if any) | Title |
|---|
| 002735 (2008) |
Maria Skaalum Petersen [Danemark] ; Pal Weihe [Danemark] ; Anna Choi [États-Unis] ; Philippe Grandjean [Danemark, États-Unis] | Increased prenatal exposure to methylmercury does not affect the risk of Parkinson's disease |
| 002737 (2008) |
Maria Skaalum Petersen [Danemark] ; Jonrit Halling [Danemark] ; Sara Bech ; Lene Wermuth [Danemark] ; Pal Weihe [Danemark] ; Flemming Nielsen [Danemark] ; Poul J. J Rgensen [Danemark] ; Esben Budtz-J Rgensen [Danemark] ; Philippe Grandjean [Danemark, États-Unis] | Impact of dietary exposure to food contaminants on the risk of Parkinson's disease |
| 003398 (2004) |
Hélène Legros [France] ; Marie-George Dingeval [France] ; Francois Janin [France] ; Jean Costentin [France] ; Jean-Jacques Bonnet [France] | Toxicity of a treatment associating dopamine and disulfiram for catecholaminergic neuroblastoma SH-SY5Y cells: Relationships with 3,4-dihydroxyphenylacetaldehyde formation |
| 003400 (2004) |
Kay Castagnoli [États-Unis] ; Thangaraju Murugesan [États-Unis] | Tobacco leaf, smoke and smoking, MAO inhibitors, Parkinson's disease and neuroprotection; are there links? |
| 003401 (2004) |
Moussa B. H. Youdim [Israël] ; Marta Weinstock [Israël] | Therapeutic applications of selective and non-selective inhibitors of monoamine oxidase A and B that do not cause significant tyramine potentiation |
| 003403 (2004) |
Michael A. Collins [États-Unis] | Tetrahydropapaveroline in Parkinson's disease and alcoholism: A look back in honor of Merton Sandler |
| 003419 (2004) |
Toshiharu Nagatsu [Japon] | Progress in monoamine oxidase (MAO) research in relation to genetic engineering |
| 003425 (2004) |
William J. Burke [États-Unis] ; SHU WEN LI [États-Unis] ; Hyung D. Chung [États-Unis] ; David A. Ruggiero [États-Unis] ; Bruce S. Kristal [États-Unis] ; Eugene M. Johnson [États-Unis] ; Patricia Lampe [États-Unis] ; Vijaya B. Kumar [États-Unis] ; Mark Franko [États-Unis] ; Evelyn A. Williams [États-Unis] ; Daniel S. Zahm [États-Unis] | Neurotoxicity of MAO metabolites of catecholamine neurotransmitters: Role in neurodegenerative diseases |
| 003428 (2004) |
Peter Riederer [Allemagne] ; Walter Danielczyk [Autriche] ; Edna Grünblatt [Allemagne] | Monoamine oxidase-B inhibition in Alzheimer's disease |
| 003452 (2004) |
Makoto Naoi [Japon] ; Wakako Maruyama [Japon] ; Georgy M. Nagy [Hongrie] | Dopamine-derived salsolinol derivatives as endogenous monoamine oxidase inhibitors: Occurrence, metabolism and function in human brains |
| 003460 (2004) |
N. Hamaue [Japon] ; M. Minami [Japon] ; M. Terado [Japon] ; M. Hirafuji [Japon] ; T. Endo [Japon] ; M. Machida [Japon] ; T. Hiroshige [Japon] ; A. Ogata [Japon] ; K. Tashiro [Japon] ; H. Saito [Japon] ; S. H. Parvez [France] | Comparative study of the effects of isatin, an endogenous MAO-inhibitor, and selegiline on bradykinesia and dopamine levels in a rat model of Parkinson's disease induced by the Japanese encephalitis virus |
| 003464 (2004) |
JEAN CHEN SHIN [États-Unis] | Cloning, after cloning, knock-out mice, and physiological functions of MAO A and B |
| 003465 (2004) |
Mitsuhiko Yamada [Japon] ; Hajime Yasuhara [Japon] | Clinical pharmacology of MAO inhibitors: Safety and future |
| 003473 (2004) |
Kalman Magyar [Hongrie] ; Béla Szende [Hongrie] | (-)-Deprenyl, a selective MAO-B inhibitor, with apoptotic and anti-apoptotic properties |
| 003524 (2003) |
Larissa Takser [France] ; Donna Mergler ; Georgette Hellier ; Josiane Sahuquillo ; Guy Huel | Manganese, monoamine metabolite levels at birth, and child psychomotor development. |
| 003729 (2003) |
Larissa Takser [France] ; Donna Mergler [Canada] ; Georgette Hellier [France] ; Josiane Sahuquillo [France] ; Guy Huel [France] | Manganese, monoamine metabolite levels at birth, and child psychomotor development |
| 004F80 (1995) |
P. Allain [France] ; A. Le Bouil ; E. Cordillet ; L. Le Quay ; H. Bagheri ; J L Montastruc | Sulfate and cysteine levels in the plasma of patients with Parkinson's disease. |
| 005184 (1995) |
P. Allain [France] ; A. Le Bouil [France] ; E. Cordillet [France] ; L. Le Quay [France] ; H. Bagheri [France] ; J. L. Montastruc | Sulfate and cysteine levels in the plasma of patients with Parkinson's disease |
| 005880 (1992) |
L. J. Anghileri [France] | Effects of complexes iron and aluminium on brain calcium |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Main/Merge
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Merge/ISSN.i -k "0161-813X"
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Merge/ISSN.i \
-Sk "0161-813X" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Merge/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonFranceV1
|flux= Main
|étape= Merge
|type= indexItem
|index= ISSN.i
|clé= 0161-813X
}}
| This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024 |  |
